SRPT
Sarepta Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$16.40
-0.64 ▼ -3.76%
🌙 3월 13일 7:31 PM ET (한국 3/14 08:31)
$16.45
+0.05 ▲ +0.30%
| Index | - | P/E | - | EPS (ttm) | -8.44 | Insider Own | 5.28% | Shs Outstand | 0.10B | Perf Week | -1.86% |
| Market Cap | 1.72B | Forward P/E | 12.53 | EPS next Y | -59.3% | Insider Trans | -0.37% | Shs Float | 0.10B | Perf Month | -8.69% |
| Enterprise Value | 1.82B | PEG | - | EPS next Q | 1.13 | Inst Own | 91.52% | Short Float | 21.36% | Perf Quarter | -26.13% |
| Income | -0.84B | P/S | 0.78 | EPS this Y | 145.11% | Inst Trans | -0.58% | Short Ratio | 7.75 | Perf Half Y | -8.43% |
| Sales | 2.20B | P/B | 1.51 | EPS next 5Y | - | ROA | -23.05% | Short Interest | 21.24M | Perf YTD | -23.79% |
| Book/sh | 10.87 | P/C | 1.83 | EPS past 3/5Y | 3.92% -0.05% | ROE | -63.17% | 52W High | -84.13% ($103.32) | Perf Year | -83.33% |
| Cash/sh | 8.95 | P/FCF | - | Sales past 3/5Y | 33.06% 32.41% | ROIC | -38.86% | 52W Low | 57.47% ($10.41) | Perf 3Y | -88.51% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -438.5% | Gross Margin | 59.56% | Volatility(W/M) | 5.76% 5.05% | Perf 5Y | -81.03% |
| Dividend TTM | - | EV/Sales | 0.83 | Sales Y/Y TTM | 15.58% | Oper. Margin | -29.92% | ATR (14) | 1.04 | Perf 10Y | 4.19% |
| Dividend Ex-Date | - | Quick Ratio | 1.48 | EPS Q/Q | -344.01% | Profit Margin | -38.34% | RSI (14) | 38.89 | Recom | 2.76 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.32 | Sales Q/Q | -32.73% | SMA20 | -6.07% ($17.46) | Beta | 0.44 | Target Price | $20.61 |
| Payout | - | Debt/Eq | 0.91 | Earnings | 2000000 | SMA50 | -15.91% ($19.5) | Rel Volume | 0.84 | Prev Close | $17.04 |
| Employees | 835 | LT Debt/Eq | 0.9 | EPS/Sales Surpr. | -228.27% 19.84% | SMA200 | -20.68% ($20.68) | Avg Volume(3M) | 2.74M | Price | $16.4 |
| IPO | 1997/6/4 | Option/Short | Yes/Yes | Trades | 19924 | Volume | 2,291,689 | Change | -3.76% |
뉴스 로딩 중...